Profile
AQST ZTS TAK HLN TEVA ITCI
Company Name Aquestive Therapeutics, Inc. Zoetis Inc. Takeda Pharmaceutical Company Limited Haleon plc Teva Pharmaceutical Industries Limited Intra-Cellular Therapies, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic
Market Cap $417.18M $67.47B $45.57B $44.51B $18.42B $14.05B
Employees 0.14K 13.80K 49.28K 24.56K 37.00K 0.86K
CEO Daniel Barber Kristin C. Peck Christophe Weber Brian James McNamara Richard D. Francis Sharon Mates
Ratings
AQST ZTS TAK HLN TEVA ITCI
Quant Rating Score 2 3 3 3 2 1
Quant Rating Sell Neutral Neutral Neutral Sell Strong Sell
Trading
AQST ZTS TAK HLN TEVA ITCI
Last Close $4.2 $148.6 $14.43 $9.6 $16.06 $131.87
High 52 $5.66 $196.48 $15.46 $11.41 $22.77 $131.91
Low 52 $2.22 $144.45 $12.89 $8.84 $12.82 $71.19
Price vs. 52 Week High -25.8 % -24.37 % -6.66 % -15.86 % -29.47 % -0.03 %
Price vs. 52 Week Low 89.19 % 2.87 % 11.95 % 8.6 % 25.27 % 85.24 %
Total Return
AQST ZTS TAK HLN TEVA ITCI
1 Month Return 29.23 % -5.45 % -2.3 % -7.78 % -5.25 % 0 %
3 Month Return 67.33 % -0.05 % -1.9 % -6.07 % 17.66 % 0 %
6 Month Return 35.48 % -10.42 % 11.69 % 3.9 % -26.73 % 4.49 %
9 Month Return -16.5 % -23.12 % 0.7 % -4.86 % -10.53 % 68.33 %
YTD Return 17.98 % -8.8 % 8.99 % 0.63 % -27.13 % 57.89 %
1 Year Return 31.25 % -16.79 % 8.01 % 7.74 % -4.46 % 76.16 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
AQST ZTS TAK HLN TEVA ITCI
Dividend Yield Percentage (TTM) - 1.23 % 4.52 % 0.01 % - -
Dividend Paid and Capex Coverage Ration (TTM) -184.06 % 2 % 1.65 % - 2.53 % -227.26 %
Dividend Per Share (TTM) - 1.86 % 196 % 0.05 % - -
Payout Ratio (TTM) - 32.25 % 280.28 % - - -
Growth
AQST ZTS TAK HLN TEVA ITCI
Asset Growth 76.64 % 8.25 % -9.55 % 87.69 %
Gross Profit Growth 33.4 % 1.76 % 5.47 % 44.88 %
Revenue Growth 13.8 % 5.87 % 4.4 % 46.62 %
Revenue 3 Year -50.28 % 33.13 % 1.52 % 556.51 %
Revenue 5 Year -68.01 % 103.83 % -5.5 % 600974.32 %
Revenue 10 Year -68.6 % 152.69 % -38.45 % 32663.23 %
EBIT Growth -16669.33 % -64.98 % -169.63 % 26.77 %
Net Income Growth -460.83 % -54.56 % -193.2 % 46.54 %
Net Income 3 Yeari Growth Per Share 78.48 % -61.74 % -482.97 % 79.29 %
Net Income 5 Yeari Growth Per Share 82.24 % 32.36 % -58.26 % 72.95 %
Net Income 10 Yeari Growth Per Share -29.85 % 35.42 % -140.46 % 32.41 %
Operating Income Growth -103.75 % -56.36 % -169.98 % 26.77 %
Operating Cash Flow Growth (CFG) -460.49 % -26.69 % -8.85 % 41.08 %
Operating 3 Year CFG 52.39 % -29.25 % 52.26 % 77.79 %
Operating 5 Year CFG 82.64 % 118.64 % 123.59 % 69.4 %
Operating 10 Year CFG -23.57 % 384.17 % -81.66 % 10.87 %
EPS Growth -292.31 % -54.92 % -190 % 50.68 %
EPS Diluted Growth -292.31 % -54.86 % -190 % 50.68 %
Book Value Per Share 60.1 % 13.54 % -30.36 % 80.54 %
Share Holder 3 Year Equity Growth Per Share 67.84 % 40.38 % -49 % 116.52 %
Share Holder 5 Year Equity Growth Per Share -187.29 % 41.33 % -62.86 % 215.14 %
Share Holder 10 Year Equity Growth Per Share 3.31 % 195.14 % -82.6 % 164.65 %
Dividend Per Share Growth - 1.95 % - -
Dividend 3 Year Growth Per Share - 1.19 % - -
Dividend 5 Year Growth Per Share - 101.42 % -100 % -
Dividend 10 Year Growth Per Share - 102.58 % -100 % -
Debt Growth 14.06 % 10.53 % -10.29 % 0.25 %
Free Cash Flow Growth -387.02 % -31.4 % -11.05 % 40.95 %
Updated On 31 Dec 2024 31 Mar 2024 31 Dec 2024 31 Dec 2024
Profitability
AQST ZTS TAK HLN TEVA ITCI
Gross Profit Margin TTM 68.4 % 70.2 % 54.7 % 61.52 % 49.17 % 91.63 %
Return on Assets TTM -53.05 % 17.86 % 0.76 % 4.2 % -3.35 % -5.46 %
Return on Equity TTM 107.41 % 51.32 % 1.48 % 8.73 % -21.38 % -7.4 %
Return on Capital Employed TTM -49.06 % 32.08 % 3.75 % 7.74 % 1.59 % -10.05 %
Net Income Per EBT TTM 99.97 % 78.79 % 61.12 % 75.5 % 246.36 % 100.64 %
EBT Per Ebit TTM 131.75 % 92.99 % 40.08 % 86.58 % -120.28 % 63.57 %
EBIT Per Revenue TTM -75.94 % 37.01 % 9.62 % 19.64 % 2.61 % -17.15 %
Cash Flow To Debt Ratio TTM -124.63 % 43.63 % 21.32 % - 7.47 % -430.93 %
Receivables Turnover TTM 5.19 6.82 6.32 5.9 4.91 4.09
Payables Turnover TTM 1.4 6.51 4.36 2.19 3.69 2.18
Inventory Turnover TTM 2.38 1.16 1.7 3.63 2.6 2.17
Fixed Asset Turnover TTM 612.75 % 253.65 % 232.78 % 584.75 % 332.7 % 4569.25 %
Asset Turnover TTM 53.04 % 65.87 % 32.15 % 32.73 % 43.25 % 49.79 %
Operating Cash Flow Per Share TTM -0.51 6.58 608.55 - 1.11 -0.71
Free Cash Flow Per Share TTM -0.51 5.1 443.26 - 0.67 -0.71
Cash Per Share TTM 71.89 % 384.5 % 24349.44 % 24.05 % 149.12 % 970.67 %
Operating Cash Flow Sales Ratio TTM -89.94 % 31.71 % 21.01 % - 7.62 % -10.75 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.54 % 77.45 % 72.84 % - 60.43 % 100.44 %
Cash Flow Coverage Ratios TTM -124.63 % 43.63 % 21.32 % - 7.47 % -430.93 %
Price To Free Cash Flows Ratio TTM -8.51 29.58 9.74 - 24.3 -191.12
Price To Operating Cash Flows Ratio TTM -8.22 23.03 7.13 - 14.57 -185.85
Price Cash Flow Ratio TTM -8.22 23.03 7.13 - 14.57 -185.85
Income Statement (TTM)
AQST ZTS TAK HLN TEVA ITCI
Revenue $0.06B $9.26B $4263.76B $11.23B $16.54B $0.68B
Gross Profit $0.04B $6.54B $2832.26B $6.95B $8.06B $0.62B
Gross Profit Ratio 68.95% 70.62% 66.43% 61.85% 48.74% 91.63%
EBITDA $-0.03B $3.87B $874.6B $2.51B $0.72B $-0.12B
Net Income $-0.04B $2.49B $144.07B $1.44B $-1.64B $-0.07B
EPS Diluted -0.51 5.47 45.58 0.32 -1.45 -0.72
Balance Sheet (MRQ)
AQST ZTS TAK HLN TEVA ITCI
Long Term Debt $0.04B $5.39B $5029.93B $8.54B $16.3B $0.01B
Total Liabilities $0.16B $9.47B $7834.79B $18.09B $33.61B $0.22B
Total Equity $-0.06B $4.77B $7274.01B $16.22B $5.72B $1.15B
Total Investments $0B $0B $445.7B $0.08B $0B $0.69B
Total Debt $0.04B $6.74B $4843.75B $10.1B $18.08B $0.02B
Total Assets $0.1B $14.24B $15108.79B $34.32B $39.33B $1.37B
Cash Flow Statement (TTM)
AQST ZTS TAK HLN TEVA ITCI
Net Income $-0.04B $2.5B $144.07B $1.44B $-1.96B $-0.07B
Inventory $0B $-0.04B $-115.74B $0.22B $0.17B $-0.01B
Dividends Paid $0B $-0.79B $-287.19B $-0.57B $0B $0B
Operating Cash Flow $-0.04B $2.95B $716.34B $2.3B $1.25B $-0.07B
Capital Expenditure $-0B $-0.66B $-480.73B $-0.25B $-0.5B $-0B
Related Stocks
Ticker Name Price
ACB Aurora Cannabis Inc. 4.53
ACOR Acorda Therapeutics, Inc. 0.661
ACRX AcelRx Pharmaceuticals, Inc. 0.86
ADMP Adamis Pharmaceuticals Corporation 0.775
ADMS Adamas Pharmaceuticals, Inc. 8.22
AERI Aerie Pharmaceuticals, Inc. 15.25
AGRX Agile Therapeutics, Inc. 1.51
AKAN Akanda Corp. 1.21
ALIM Alimera Sciences, Inc. 5.54
ALVO Alvotech 8.63
ALVOW Alvotech 1.65
AMPH Amphastar Pharmaceuticals, Inc. 20.62
AMRX Amneal Pharmaceuticals, Inc. 7.97
AMYT Amryt Pharma plc 14.7
ANIP ANI Pharmaceuticals, Inc. 66.3
APUS Apimeds Pharmaceuticals US, Inc 1.77
ASRT Assertio Holdings, Inc. 0.673
ATNX Athenex, Inc. 0.2031
AVDL Avadel Pharmaceuticals plc 10.83
AYTU Aytu BioPharma, Inc. 2.37
ETFs With Exposure to AQST
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0.01294 222.33
VTI Vanguard Total Stock Market Index Fund 0 309.09
ITOT iShares Core S&P Total U.S. Stock Market ETF 0.00085 137.38
IWN iShares Russell 2000 Value ETF 0.01763 163.34
IWV iShares Russell 3000 ETF 0.00083 357.07
IWO iShares Russell 2000 Growth ETF 0.00869 292.76
BIB ProShares Ultra Nasdaq Biotechnology 0.029226 49.1234
VXF Vanguard Extended Market Index Fund 0 198.49
HDG ProShares Hedge Replication ETF 0.00175391 50.0204
UWM ProShares Ultra Russell2000 0.00988303 39.82
VTHR Vanguard Russell 3000 Index Fund 0 277.193
IWC iShares Micro-Cap ETF 0.0905 133.64
DWAS Invesco DWA SmallCap Momentum ETF 0.271 85.3667
URTY ProShares UltraPro Russell2000 0.00801604 42.58
VTWV Vanguard Russell 2000 Value Index Fund 0.01 143.956
GSSC Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF 0.03 69.499
OMFS Invesco Russell 2000 Dynamic Multifactor ETF 0.034 40.835
PTH Invesco DWA Healthcare Momentum ETF 0.439 37.7319
VFMO Vanguard U.S. Momentum Factor ETF 0.09 175.82
VTWG Vanguard Russell 2000 Growth Index Fund 0.01 213.781
VTWO Vanguard Russell 2000 Index Fund 0.01 89.86
XAW.TO iShares Core MSCI All Country World ex Canada Index ETF 0 46.95
XUU.TO iShares Core S&P U.S. Total Market Index ETF 0 63.55
XUH.TO iShares Core S&P U.S. Total Market Index ETF (CAD-Hedged) 0 51.12
XTR.TO iShares Diversified Monthly Income ETF 0 11.37
XSU.TO iShares U.S. Small Cap Index ETF (CAD-Hedged) 0.01 42.51
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 105.15
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 105.13
VBAIX Vanguard Balanced Index Fund Institutional Shares 0 50.21
VBIAX Vanguard Balanced Index Fund Admiral Shares 0 50.2
VBINX Vanguard Balanced Index Fund Investor Shares 0 50.21
XBAL.TO iShares Core Balanced ETF Portfolio 0 31.19
XCNS.TO iShares Core Conservative Balanced ETF Portfolio 0 24.08
XEQT.TO iShares Core Equity ETF Portfolio 0 36.035
XGRO.TO iShares Core Growth ETF Portfolio 0 32.07
XINC.TO iShares Core Income Balanced ETF Portfolio 0 20.55
IBBQ Invesco Nasdaq Biotechnology ETF 0.043 21.9211
2B70.DE iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.04266 5.57
VTSAX Vanguard Total Stock Market Index Fund 0 150.5
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.04266 6.48375
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 150.58
VITSX Vanguard Total Stock Market Index Fund 0 150.53
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF 0.04266 6.457
QQQS Invesco NASDAQ Future Gen 200 ETF 0.638 27.9628
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.00023529 106.49
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 150.59
BTEK.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.04266 4.8235
JKJ iShares Morningstar Small-Cap ETF 0 231.193
JKL iShares Morningstar Small-Cap Value ETF 0.01 172.726
VEMPX Vanguard Extended Market Index InstlPlus 0 371.61
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 282.37
RSSL Global X Funds 0.01 87.47
RFLR Innovator ETFs Trust 0.01 26.025
Unlock